2003
DOI: 10.1016/s0012-1606(03)00106-4
|View full text |Cite
|
Sign up to set email alerts
|

Temporal effects of Sprouty on lung morphogenesis

Abstract: Paracrine signaling mediated by FGF-10 and the FGF-R2IIIb receptor is required for formation of the lung. To determine the temporal requirements for FGF signaling during pulmonary morphogenesis, Sprouty-4 (Spry-4), an intracellular FGF receptor antagonist, was expressed in epithelial cells of the fetal lung under control of a doxycycline-inducible system. Severe defects in lobulation and severe lung hypoplasia were observed when Spry-4 was expressed throughout fetal lung development (E6.5-E18.5) or from E6.5 u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
37
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 62 publications
(40 citation statements)
references
References 28 publications
3
37
0
Order By: Relevance
“…In previous studies from our laboratory, the ability of the FGFR-HFc to inhibit effects of FGF-7 on lung branching was shown in vitro and in vivo (16). No effects of Sprouty-4 or FGFR-HFc receptors were observed in the postnatal period under physiological conditions (16,27). Although FGF ligands are present in the adult lung, it is unclear whether FGF signaling plays a role in postnatal lung homeostasis.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…In previous studies from our laboratory, the ability of the FGFR-HFc to inhibit effects of FGF-7 on lung branching was shown in vitro and in vivo (16). No effects of Sprouty-4 or FGFR-HFc receptors were observed in the postnatal period under physiological conditions (16,27). Although FGF ligands are present in the adult lung, it is unclear whether FGF signaling plays a role in postnatal lung homeostasis.…”
Section: Discussionmentioning
confidence: 93%
“…Targeted deletion of FGF-10, the FGFR2IIIb receptor, expression of a dominant-negative FGF receptor or Sprouty, an intracellular FGF antagonist, blocked lung morphogenesis during the early embryonic period (13,16,20,23,27). Although inhibition of FGF signaling until embryonic day 12 caused severe lung hypoplasia, the effects were less extensive when FGF inhibition was induced later in gestation.…”
Section: Discussionmentioning
confidence: 99%
“…The generation of transgenic FVB/N mice that conditionally express a soluble dominant-negative FGF receptor (FGFR-Hc) in the lung has been described elsewhere (18). Generation of transgenic mice conditionally expressing the FGF antagonist Sprouty-4 (Spry-4) in the developing lung epithelium has been described (19). Timed-pregnant females of both transgenic strains were given doxycycline in their food (625 mg/kg; Harlan-Teklad, Madison, WI) beginning on day E0.5, and embryonic lungs were harvested on day E13.5.…”
Section: Methodsmentioning
confidence: 99%
“…Mammalian Sprys have been shown to particularly function as negative regulators in FGF signaling during vertebrate embryonic development. The overexpression of mouse Spry2 or Spry4 results in the repression of FGF-mediated limb development in the chick (15) and inhibition of lung branching morphogenesis (14,18,19). In addition, the overexpression of mSpry4 in mouse embryos inhibited branching and sprouting of small blood vessels (20).…”
Section: Introductionmentioning
confidence: 99%